Anita Balakrishnan

@HPBCambridge

Consultant Hepatopancreatobiliary Surgeon @CUH_NHS, Affiliated Asst Professor @CambridgeUni, Fellow @Selwyn1882, Hunterian Professor 2017, @EAHPBA Council

Cambridge, England Joined December 2017

373 Following 800 Followers 730 Posts

Latest posts 5

Pinned post

Anita Balakrishnan @HPBCambridge Jun 21, 2025

Honoured to be appointed @EAHPBA Chair of the Scientific and Research Committee. Looking forward to working with our excellent committee members to further #HPB research in Europe, Africa and the Middle East, and collaborate with @AHPBA and @APHPBA and beyond! @IHPBA

Anita Balakrishnan @HPBCambridge Oct 31

Excited to be a part of this important initiative on #gallbladdercancer @IHPBA @EAHPBA

Shailesh V. Shrikhande @Shrikhande_SV Oct 28

Excellent work led by @DrPJagannath @ItaruEndo @DrVAChaudhari privilege to continue this important consensus process that we started @APHPBA2023
View quoted post on X

Anita Balakrishnan @HPBCambridge Oct 11

Can a tiny pancreatic cancer biopsy predict chemotherapy response? @mo_lotfollahi and I are recruiting a CRUK Cambridge Clinical PhD combining spatial transcriptomics, AI and patient samples to develop personalised treatment strategies. Come join us! crukcambridgecentre.org.uk/education-and-…

Anita Balakrishnan @HPBCambridge Aug 4

Excited to present the latest paper from the @HPB_OMEGA_study confirming that fitness matters more than age alone when considering resection for #gallbladdercancer @CUH_NHS @Cambridge_Uni @EAHPBA @IHPBA @CharityAMMF @curecc Huge effort from all our international collaborators 🙏

BJS Open Verified account @BjsOpen Aug 4

Age ≥75 years predicts poorer survival but not higher complication rates after curative gallbladder cancer resection
➡️doi.org/10.1093/bjsope…

The prognostic influence of age on outcomes after gallbladder cancer (GBC) resection has been poorly characterised relative to other hepatopancreatobiliary malignancies. This international, multicentre retrospective cohort study analysed 3676 patients undergoing curative GBC resection across 133 centres in 41 countries (2010–2020), comparing outcomes in patients aged ≥75 years versus younger patients using propensity score matching. Older adults underwent less extensive surgery and lymphadenectomy and received adjuvant chemotherapy less frequently, and age ≥75 years was independently associated with poorer overall survival in both unmatched (HR 1.34) and matched (HR 1.31) cohorts, while recurrence-free survival and postoperative complication rates did not differ significantly by age group. The authors conclude that fitness rather than chronological age alone should guide eligibility for curative treatment, including major resection and adjuvant chemotherapy.

👏👏👏@HPBCambridge, Petros Barmpounakis, Nikolaos Demiris, Bodil Andersson, Alejandro Brañes, Xavier de Aretxabala, Paul Gibbs, Simon J F Harper, Emmanuel L Huguet, Asif Jah, Vasilis Kosmoliaptsis, Javier Lendoire, Siong S Liau, Shishir K Maithel, Jack L Martin, Colin Noel, Raaj K Praseedom, Alejandro Serrablo, Volkan Adsay, on behalf of the OMEGA Study Investigators
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery #HPBSurgery #SurgicalOncology #GeriatricSurgery #CancerSurgery

View quoted post on X

Anita Balakrishnan @HPBCambridge Jul 12

Check out our OMEGA GBC Study website and the online calculator for prediction of nodal involvement! @eahpba @CharityAMMF @cureGBC @curecc @CUH_NHS

OMEGA Gallbladder Cancer Study @HPB_OMEGA_study Jul 12

The OMEGA Study website is now live! Our international collaborative spans 133 centres across 41 countries , building the evidence base for gallbladder cancer surgery. Explore our research, online risk calculators and collaborator list: omegagallbladdercancerstudy.github.io/omega-study/
#GallbladderCancer
View quoted post on X